Erika Carmel-Tech (ERKA) Stock Overview
Develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
ERKA Community Fair Values
See what others think this stock is worth. Follow their fair value or set your own to get alerts.
Erika Carmel-Tech Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₪0.21 |
52 Week High | ₪0.30 |
52 Week Low | ₪0.15 |
Beta | 1.2 |
1 Month Change | 20.90% |
3 Month Change | -22.74% |
1 Year Change | -8.15% |
3 Year Change | 12.04% |
5 Year Change | n/a |
Change since IPO | -96.57% |
Recent News & Updates
Erika B-Cure Laser Ltd (TLV:BCUR) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough
Sep 16Erika B-Cure Laser Ltd's (TLV:BCUR) Shares Bounce 27% But Its Business Still Trails The Industry
Jul 10The Market Doesn't Like What It Sees From Erika B-Cure Laser Ltd's (TLV:BCUR) Revenues Yet
May 09Recent updates
Shareholder Returns
ERKA | IL Medical Equipment | IL Market | |
---|---|---|---|
7D | 22.3% | 2.5% | -1.9% |
1Y | -8.2% | 27.0% | 54.8% |
Return vs Industry: ERKA underperformed the IL Medical Equipment industry which returned 25.5% over the past year.
Return vs Market: ERKA underperformed the IL Market which returned 53.8% over the past year.
Price Volatility
ERKA volatility | |
---|---|
ERKA Average Weekly Movement | 12.7% |
Medical Equipment Industry Average Movement | 5.8% |
Market Average Movement | 5.1% |
10% most volatile stocks in IL Market | 7.8% |
10% least volatile stocks in IL Market | 3.5% |
Stable Share Price: ERKA's share price has been volatile over the past 3 months compared to the IL market.
Volatility Over Time: ERKA's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of IL stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | 44 | Ronen Goldstein | bcurelaser.com |
Erika Carmel-Tech Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It offers B-Cure Laser Classic, a non-invasive and safe medical device for the treatment of chronic and acute pain for home use; and B-Cure Laser Pro, a clinically proven, non-invasive and safe medical device for treatment of both acute and chronic conditions. The company treats achilles tendon inflammation, burns, carpal tunnel syndrome, finger joint pain, fibromyalgia, hip pain, post-dental treatment, lower back pain, neck pain, shoulder pain, knee pain, tennis elbow, to joint pain, temporomandibular joint disorders, upper back pain, and wounds.
Erika Carmel-Tech Ltd Fundamentals Summary
ERKA fundamental statistics | |
---|---|
Market cap | ₪22.29m |
Earnings (TTM) | -₪11.45m |
Revenue (TTM) | ₪39.63m |
Is ERKA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ERKA income statement (TTM) | |
---|---|
Revenue | ₪39.63m |
Cost of Revenue | ₪15.45m |
Gross Profit | ₪24.19m |
Other Expenses | ₪35.64m |
Earnings | -₪11.45m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
Earnings per share (EPS) | -0.11 |
Gross Margin | 61.03% |
Net Profit Margin | -28.90% |
Debt/Equity Ratio | 0.07% |
How did ERKA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/10/22 00:16 |
End of Day Share Price | 2025/10/22 00:00 |
Earnings | 2025/06/30 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Erika Carmel-Tech Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.